Switch theme
Sign up to access all valuation multiples
Aevis Victoria SA is a medical care company with five segments: Healthcare, Hospitality, Real Estate, Others, and Corporate. The Healthcare business segment operates private hospitals and clinics. The Hospitality business segment owns and operates hospitals. The Real Estate segment operates healthcare-related real estate properties. The Others segment provides ambulance services, such as urgent patient transport and hospital transfers. The Corporate segment operates other miscellaneous business activities. It generates the vast majority of its revenue in Healthcare segment.
2006
4.7K+
LTM Revenue $1.3B
LTM EBITDA $117M
$2.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Aevis Victoria has a last 12-month revenue (LTM) of $1.3B and a last 12-month EBITDA of $117M.
In the most recent fiscal year, Aevis Victoria achieved revenue of $1.3B and an EBITDA of $122M.
Aevis Victoria expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Aevis Victoria valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| Gross Profit | n/a | XXX | $994M | XXX | XXX | XXX |
| Gross Margin | n/a | XXX | 78% | XXX | XXX | XXX |
| EBITDA | $117M | XXX | $122M | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 10% | XXX | XXX | XXX |
| EBIT | $35.4M | XXX | -$30.7M | XXX | XXX | XXX |
| EBIT Margin | 3% | XXX | -2% | XXX | XXX | XXX |
| Net Profit | $7.1M | XXX | -$3.6M | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 0% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.3B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 18, 2025, Aevis Victoria's stock price is CHF 14 (or $17).
Aevis Victoria has current market cap of CHF 1.1B (or $1.4B), and EV of CHF 2.2B (or $2.7B).
See Aevis Victoria trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.7B | $1.4B | XXX | XXX | XXX | XXX | $0.45 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 18, 2025, Aevis Victoria has market cap of $1.4B and EV of $2.7B.
Aevis Victoria's trades at 2.2x EV/Revenue multiple, and 22.4x EV/EBITDA.
Equity research analysts estimate Aevis Victoria's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Aevis Victoria has a P/E ratio of 200.9x.
See valuation multiples for Aevis Victoria and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| EV (current) | $2.7B | XXX | $2.7B | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | 23.5x | XXX | 22.4x | XXX | XXX | XXX |
| EV/EBIT | 77.3x | XXX | -89.2x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | 200.9x | XXX | -396.8x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -115.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAevis Victoria's last 12 month revenue growth is 9%
Aevis Victoria's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Aevis Victoria's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Aevis Victoria's rule of X is 32% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Aevis Victoria and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | 39% | XXX | XXX | XXX |
| Rule of 40 | 15% | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 81% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Aevis Victoria acquired XXX companies to date.
Last acquisition by Aevis Victoria was XXXXXXXX, XXXXX XXXXX XXXXXX . Aevis Victoria acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Aevis Victoria founded? | Aevis Victoria was founded in 2006. |
| Where is Aevis Victoria headquartered? | Aevis Victoria is headquartered in Switzerland. |
| How many employees does Aevis Victoria have? | As of today, Aevis Victoria has 4.7K+ employees. |
| Is Aevis Victoria publicy listed? | Yes, Aevis Victoria is a public company listed on SWX. |
| What is the stock symbol of Aevis Victoria? | Aevis Victoria trades under AEVS ticker. |
| When did Aevis Victoria go public? | Aevis Victoria went public in 1999. |
| Who are competitors of Aevis Victoria? | Similar companies to Aevis Victoria include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Aevis Victoria? | Aevis Victoria's current market cap is $1.4B |
| What is the current revenue of Aevis Victoria? | Aevis Victoria's last 12 months revenue is $1.3B. |
| What is the current revenue growth of Aevis Victoria? | Aevis Victoria revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Aevis Victoria? | Current revenue multiple of Aevis Victoria is 2.1x. |
| Is Aevis Victoria profitable? | Yes, Aevis Victoria is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Aevis Victoria? | Aevis Victoria's last 12 months EBITDA is $117M. |
| What is Aevis Victoria's EBITDA margin? | Aevis Victoria's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Aevis Victoria? | Current EBITDA multiple of Aevis Victoria is 23.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
